NCT01503151

Brief Summary

Adults with Social Phobia will be randomly assigned to either an attention bias modification treatment, interpretation bias modification treatment, both, or a placebo control condition not designed to change cognitive bias patterns. Outcome measures will be social anxiety symptoms and severity as measured by gold standard questionnaires as well as diagnosis of social phobia disorder and symptom counts derived from structured clinical interviews based on DSM-IV criteria. The investigators expect to find significant reduction in social anxiety symptoms in the Treatment groups relative to the placebo control group. The investigators want to find out the relative efficacy of attention and interpretation oriented treatments and the combination of the two.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2011

Completed
3 days until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 2, 2012

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

December 2, 2014

Status Verified

December 1, 2014

Enrollment Period

2.2 years

First QC Date

December 29, 2011

Last Update Submit

December 1, 2014

Conditions

Keywords

attention bias modification treatmentinterpretive bias modificationcognitive bias modificationattention trainingsocial anxiety

Outcome Measures

Primary Outcomes (1)

  • Social Anxiety Scale (LSAS) - diagnostic interview

    LSAS is a 24-items clinician-administered scale developed for the assessment of fear and avoidance associated with social. The LSAS assesses a wide range of both social interaction and performance/observation situations, which are rated for degree of fear/anxiety and frequency of avoidance.

    Expected time frame of 6 weeks per participant. Participants will be assessed before and after the administration of the training/control protocols

Secondary Outcomes (1)

  • The Mini International Neuropsychiatric Interview (MINI).

    expected time frame of 6 weeks per participant. Participants will be assessed before and after the administration of the training/control protocols

Study Arms (4)

Placebo

PLACEBO COMPARATOR

repeated trials of a dot-probe task and repeated trials of an interpretation task, both not intended to change threat-related biases patterns.

Behavioral: Control Condition

Attention Bias Modification (ABM)

EXPERIMENTAL

Attention training via repeated trials of a dot-probe task intended to direct attention away from threat stimuli.

Behavioral: Attention Bias Modification Treatment (ABMT)

Interpretation Bias Modification (IBM)

EXPERIMENTAL

Interpretation training intended to facilitating a more benign interpretation bias

Behavioral: Interpretation Bias Modification (IBM)

Attention and interpretation biases modification

EXPERIMENTAL

Attention and interpretation training intended to direct cognitive biases away from threat stimulus.

Behavioral: Attention and Interpretive biases modification (CBM)

Interventions

Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns.

Attention Bias Modification (ABM)

Interpretive Bias Modification Treatment (IBMT) using a computerized task modified to facilitate a more benign interpretation bias.

Interpretation Bias Modification (IBM)

Attention and interpretation training using a computerized tasks not intended to alter threat-related biases patterns.

Placebo

Attention and interpretation training via computerized tasks intended to direct attention away from threat stimuli and to facilitate a more benign interpretation bias.

Attention and interpretation biases modification

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • People suffering from social anxiety

You may not qualify if:

  • Pharmacological or Psychological treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel-Aviv University

Tel Aviv, Israel

Location

MeSH Terms

Conditions

Phobia, Social

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Principal Investigator

Study Record Dates

First Submitted

December 29, 2011

First Posted

January 2, 2012

Study Start

January 1, 2012

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

December 2, 2014

Record last verified: 2014-12

Locations